Mark E. Saad - Jun 7, 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Stock symbol
AXSM
Transactions as of
Jun 7, 2024
Transactions value $
$0
Form type
4
Date filed
6/11/2024, 04:30 PM
Previous filing
Feb 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +5.8K $0.00 5.8K Jun 7, 2024 Common Stock 5.8K $73.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in full on the one-year anniversary of the date of grant, June 7, 2025.